The First Affiliated Hospital, Xi'an Jiaotong University Health Science Center, Xi'an, China; Key Laboratory of Shaanxi Province for Craniofacial Precision Medicine Research, College of Stomatology, Xi'an Jiaotong University, Xi'an, China; School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Clin Nutr. 2021 Dec;40(12):5662-5673. doi: 10.1016/j.clnu.2021.10.005. Epub 2021 Oct 12.
BACKGROUND & AIMS: Epidemiologic studies are inconsistent regarding the association of dietary omega-3 polyunsaturated fatty acids (PUFA) and/or fish intake with risk of age-related macular degeneration (AMD) incidence and progression. The objective was to determine these associations by conducting a meta-analysis of available studies.
Three electronic databases were searched for studies that quantified dietary omega-3 PUFA and/or fish intake from inception to December 2020 without language restriction. Three investigators independently assessed for inclusion and extracted data. Study-specific risk estimates were combined using random-effects model. Potential dose-response associations were explored with the use of generalized least-squares trend estimation.
21 studies were included in the meta-analysis. Higher dietary intakes of omega-3 PUFA was significantly associated with 14% (relative risk [RR]: 0.86, 95% confidence interval [CI]: 0.77, 0.96) and 29% (RR: 0.71, 95% CI: 0.55, 0.91) lower risk of early and late AMD, respectively. The dose-response analysis showed a 6% and 22% decrease in the risk of early and late AMD for each additional 1 g/d omega-3 PUFA intake. For individual omega-3 PUFA, the intake of eicosapentaenoic acid and docosahexaenoic acid was inversely associated with lower AMD risk, whereas no association was found for the alpha-linolenic acid. Consistent inverse associations were also found between fish intake and AMD. The pooled RRs comparing extreme categories of fish intake were 0.79 (95% CI: 0.70, 0.90) and 0.71 (95% CI: 0.60, 0.85) for early and late AMD risk, respectively. Every 15 g/d of fish consumption was associated with 13% and 14% lower early and late AMD. In addition, fish intake was associated with a significantly reduced risk of AMD progression (RR: 0.73, 95% CI: 0.53, 1.00).
A high intake of dietary omega-3 PUFA or fish was associated with a reduced risk of developing of AMD, which further supports that consumption of omega-3 PUFA-rich foods may be a new avenue nutritional approach to preventing AMD.
关于膳食ω-3 多不饱和脂肪酸(PUFA)和/或鱼类摄入与年龄相关性黄斑变性(AMD)发病和进展风险的相关性,流行病学研究结果并不一致。本研究的目的是通过对现有研究进行荟萃分析来确定这些相关性。
无语言限制地从建库至 2020 年 12 月,在 3 个电子数据库中搜索定量评估膳食 ω-3 PUFA 和/或鱼类摄入的研究。3 位研究者独立评估纳入情况并提取数据。使用随机效应模型合并研究特异性风险估计值。使用广义最小二乘趋势估计法探索潜在的剂量-反应关系。
荟萃分析纳入了 21 项研究。较高的膳食 ω-3 PUFA 摄入量与早期 AMD 发病风险降低 14%(相对风险 [RR]:0.86,95%置信区间 [CI]:0.77,0.96)和晚期 AMD 发病风险降低 29%(RR:0.71,95% CI:0.55,0.91)显著相关。剂量-反应分析显示,ω-3 PUFA 摄入量每增加 1 g/d,早期和晚期 AMD 的发病风险分别降低 6%和 22%。对于个体 ω-3 PUFA,二十碳五烯酸和二十二碳六烯酸的摄入量与 AMD 风险降低呈负相关,而 α-亚麻酸则没有关联。鱼类摄入量与 AMD 之间也存在一致的负相关关系。比较鱼类摄入量极值类别的汇总 RR 分别为 0.79(95% CI:0.70,0.90)和 0.71(95% CI:0.60,0.85),用于早期和晚期 AMD 风险。鱼类摄入量每增加 15 g/d,早期和晚期 AMD 的发病风险分别降低 13%和 14%。此外,鱼类摄入与 AMD 进展风险显著降低相关(RR:0.73,95% CI:0.53,1.00)。
高膳食 ω-3 PUFA 或鱼类摄入量与 AMD 发病风险降低相关,这进一步支持摄入富含 ω-3 PUFA 的食物可能是预防 AMD 的一种新的营养途径。